Suppr超能文献

儿科处方医生对注意缺陷/多动障碍的兴奋剂管理:兴奋剂给药策略综述及新型兴奋剂概述

Stimulant Management of Attention-Deficit/Hyperactivity Disorder for the Pediatric Prescriber: A Review of Stimulant-Dosing Strategies and An Overview of New Stimulants.

作者信息

Romba Courtney, Singh Jasleen

出版信息

Pediatr Ann. 2025 Jan;54(1):e22-e26. doi: 10.3928/19382359-20241007-06. Epub 2025 Jan 1.

Abstract

Pediatricians are often the first providers to assess and treat attention-deficit/hyper-activity disorder (ADHD) in youth. While a variety of pharmacological and psychosocial interventions exist for ADHD, stimulants remain the first-line medication treatment. Many stimulant formulations now exist, providing the pediatric prescriber with a diverse repertoire of treatment options. This article is tailored to the pediatric prescriber in the primary care setting and discusses stimulant management, with emphasis on dosing equivalencies, common stimulant-dosing strategies, and newer stimulants. .

摘要

儿科医生通常是评估和治疗青少年注意力缺陷多动障碍(ADHD)的首批医疗人员。虽然针对ADHD有多种药物和心理社会干预措施,但兴奋剂仍然是一线药物治疗方法。现在有许多兴奋剂制剂,为儿科开处方者提供了多种多样的治疗选择。本文是为基层医疗环境中的儿科开处方者量身定制的,讨论了兴奋剂管理,重点是剂量等效性、常见的兴奋剂给药策略和新型兴奋剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验